Reducing Skin Tone Inequities in Chronic Venous Insufficiency
Launched by KING'S COLLEGE LONDON · Jan 23, 2025
Trial Information
Current as of August 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving how doctors assess chronic venous insufficiency (CVI), which is a condition that affects blood flow in the veins of the legs, particularly in people with dark skin tones. The goal is to understand the experiences of patients with dark skin who have CVI and to develop better ways for healthcare providers to recognize skin changes related to this condition. The study will involve talking to patients about their experiences and documenting how their skin looks and feels. This information will help create guidelines that can improve care for individuals with similar conditions in the future.
To participate in this trial, individuals must have chronic venous insufficiency and a dark skin tone, as defined by specific guidelines. Participants should be able to provide informed consent and may need to return to the hospital for assessments and photography of their skin. The trial is not currently recruiting participants, but it aims to enhance the understanding of CVI in patients with dark skin tones, which is an important step toward reducing health disparities in care.
Gender
ALL
Eligibility criteria
- • Work-package 1 - Mapping patient journeys and patient experiences Participant inclusion criteria
- • people with chronic venous insufficiency, or their close family member
- • the person with chronic venous insufficiency has a dark skin tone (from Ho and Robinson skin tone range 2b-6b, table 1).
- • ability to give informed consent Participant exclusion criteria
- • person with chronic venous insufficiency has a light skin tone (from Ho and Robinson skin tone range 1a-2a, table 1).
- • people unable to speak and understand English
- • people unable to give informed consent.
- • Work package 2 - Informing skin assessment technique and medical photography Participant inclusion criteria
- • people diagnosed with chronic venous insufficiency at NHS trust
- • people with a dark skin tones (from Ho and Robinson skin tone range 2b-6b, table 1).
- • ability to give informed consent
- • either coming back to the hospital for surgery or being able to travel back to the hospital to undergo physical assessment and skin photography prior to any intervention.
- • have duplex ultra-sound scan informing clinical diagnosis of venous disease. Participant exclusion criteria
- • person with chronic venous insufficiency has a light skin tones (from Ho and Robinson skin tone range 1a-2a, table 1).
- • people unable to speak and understand English
- • people unable to give informed consent.
About King's College London
King's College London is a prominent research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the college leverages its extensive expertise in medicine, neuroscience, and public health to conduct rigorous studies aimed at improving patient outcomes. As a sponsor of clinical trials, King's College London prioritizes ethical standards, participant safety, and scientific integrity, fostering an environment that encourages groundbreaking research and the translation of findings into clinical practice. Through its state-of-the-art facilities and a diverse network of researchers, the institution strives to address critical health challenges and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Victoria J Clemett, PhD, BNurs
Principal Investigator
King' College London
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported